254 related articles for article (PubMed ID: 15252773)
1. Role of nitric oxide in diabetic nephropathy.
Prabhakar SS
Semin Nephrol; 2004 Jul; 24(4):333-44. PubMed ID: 15252773
[TBL] [Abstract][Full Text] [Related]
2. Paradoxes of nitric oxide in the diabetic kidney.
Komers R; Anderson S
Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1121-37. PubMed ID: 12736164
[TBL] [Abstract][Full Text] [Related]
3. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
[TBL] [Abstract][Full Text] [Related]
4. Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes.
Khamaisi M; Keynan S; Bursztyn M; Dahan R; Reinhartz E; Ovadia H; Raz I
Nephron Physiol; 2006; 102(3-4):p72-80. PubMed ID: 16319502
[TBL] [Abstract][Full Text] [Related]
5. Renal nitric oxide production during the early phase of experimental diabetes mellitus.
Keynan S; Hirshberg B; Levin-Iaina N; Wexler ID; Dahan R; Reinhartz E; Ovadia H; Wollman Y; Chernihovskey T; Iaina A; Raz I
Kidney Int; 2000 Aug; 58(2):740-7. PubMed ID: 10916097
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
[TBL] [Abstract][Full Text] [Related]
8. Chronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats.
Ito D; Cao P; Kakihana T; Sato E; Suda C; Muroya Y; Ogawa Y; Hu G; Ishii T; Ito O; Kohzuki M; Kiyomoto H
PLoS One; 2015; 10(9):e0138037. PubMed ID: 26379244
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats.
Choi KC; Lee SC; Kim SW; Kim NH; Lee JU; Kang YJ
Korean J Intern Med; 1999 Jan; 14(1):32-41. PubMed ID: 10063312
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
[TBL] [Abstract][Full Text] [Related]
11. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
[TBL] [Abstract][Full Text] [Related]
12. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
El-Din Bessa SS; Hamdy SM
Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H
Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
[TBL] [Abstract][Full Text] [Related]
14. Pathogenetic mechanisms of diabetic nephropathy.
Schena FP; Gesualdo L
J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S30-3. PubMed ID: 15938030
[TBL] [Abstract][Full Text] [Related]
15. Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production.
Erdely A; Freshour G; Maddox DA; Olson JL; Samsell L; Baylis C
Diabetologia; 2004 Oct; 47(10):1672-6. PubMed ID: 15490111
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
De Vriese AS; Stoenoiu MS; Elger M; Devuyst O; Vanholder R; Kriz W; Lameire NH
Kidney Int; 2001 Jul; 60(1):202-10. PubMed ID: 11422752
[TBL] [Abstract][Full Text] [Related]
17. [Dual role of nitric oxide in the pathogenesis of diabetic nephropathy].
Ksiazek K; Witowski J
Przegl Lek; 2002; 59(3):153-7. PubMed ID: 12184028
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
Kanetsuna Y; Takahashi K; Nagata M; Gannon MA; Breyer MD; Harris RC; Takahashi T
Am J Pathol; 2007 May; 170(5):1473-84. PubMed ID: 17456755
[TBL] [Abstract][Full Text] [Related]
19. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibition in a spontaneously hypertensive rat model of diabetic nephropathy.
Wessels J; Peake P; Pussell BA; Macdonald GJ
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):451-3. PubMed ID: 9171957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
